ClinicalTrials.Veeva

Menu

Incidence and Risk of Influenza in Myasthenic Patients

C

Centre d'Investigation Clinique et Technologique 805

Status

Completed

Conditions

Myasthenic Crisis
Upper Respiratory Infection

Study type

Observational

Funder types

Other

Identifiers

NCT03884777
CIC1429

Details and patient eligibility

About

Upper respiratory infection , including influenza, may exacerbate the symptoms of myasthenia gravis (MG), which is an autoimmune disease that causes muscle weakness and, in some cases, can precipitate a myasthenic crisis

In the present study, we investigated the incidence and risk factors of influenza infection on in myasthenia gravis patients.

Full description

This is a descriptive study. The data will be analyzed retrospectively . Inclusion of 416 cases of influenza in myasthenic patients treated in the intensive care unit of Garches Hospital between January 1, 2009 and December 31, 2017.

Patients who meet the inclusion and non inclusion criteria and do not object to participate in the study will be collected in a database for analysis.

Enrollment

400 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men or women over the age of 18.
  • Myasthenic patients hospitalized in intensive care.
  • Patients with confirmed influenza infection

Exclusion criteria

  • Age <18 years,
  • Other neuromuscular diseases,
  • Patient opposing the use of his data

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems